Parameter | Lipid apheresis group | Control group | p-value* |
---|---|---|---|
 | (n=16 patients) | (n=32 patients) |  |
Age ± 1 SD [years] | 63.5 ± 9,1 | 73.9 ± 9.2 | <0.05 |
Male [%] | 68,8% | 84.4% | ns |
Body Mass Index | 26.5 ± 4.4 | 25.1 ± 5.3 | ns |
Established CAD [%] | 100% | 21.9% | <0.001 |
Risk Factors | |||
Hypercholesterolemia [%] | 100% | 53.3% | 0.008 |
Arterial Hypertension, [%] | 75% | 68.8% | ns |
Active Nicotine Abuse [%] | 6.3% | 28.1% | ns |
Former Nicotine Abuse [%] | 50% | 40.7% | ns |
Diabetes Mellitus [%] | 18.8% | 21.9% | ns |
Family History of CAD or CVD [%] | 68.8% | 34.4% | 0.03 |
Serum Lipids | |||
Total Cholesterol [mg/dl] | 148.8 ± 37.7 | 200.8 ± 47.1 | <0.001 |
Triglycerides [mg/dl] | 139.1 ± 93.9 | 142.0 ± 73.5 | ns |
LDL [mg/dl] | 94.7 ± 28.9 | 128.3 ± 35.8 | <0.001 |
VLDL [mg/dl] | 18.6 ± 7.9 | 22.4 ± 10.4 | ns |
HDL [mg/dl] | 49.3 ± 12.7 | 48.2 ± 9.2 | ns |
LDL/HDL | 2.0 ± 1.0 | 2.8 ± 0.8 | 0.008 |
Lipoprotein (a) [mg/dl] | 59.9 ± 66.6 | 47.4 ± 49.4 | ns |